Related references
Note: Only part of the references are listed.Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with hodgkin lymphoma
Zeev Blumenfeld et al.
FERTILITY AND STERILITY (2008)
Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients
M. Huser et al.
HUMAN REPRODUCTION (2008)
Cancer and fertility preservation: fertility preservation in breast cancer patients
Theodoros Maltaris et al.
BREAST CANCER RESEARCH (2008)
Pregnancy in women who had cancer in childhood
Angela B. Edgar et al.
EUROPEAN JOURNAL OF CANCER (2007)
How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to Cryopreservation of embrya, oocytes, or ovaries
Zeev Blumenfeld
ONCOLOGIST (2007)
Spontaneous pregnancy and normal delivery after repeated autologous bone marrow transplantation and GnRH agonist treatment
Tsila Zuckerman
HUMAN REPRODUCTION (2007)
Prevention and treatment of uterine bleeding in hematologic malignancy
Alexander M. Quaas et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2007)
Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage
Atsushi Imai et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2007)
Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate
Dror Meirow et al.
CANCER (2006)
Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study
Charles A. Sklar et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: The PREGO-Study
Karin Manger et al.
AUTOIMMUNITY REVIEWS (2006)
Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma
F Recchia et al.
CANCER (2006)
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients
L Del Mastro et al.
ANNALS OF ONCOLOGY (2006)
Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus
EC Somers et al.
ARTHRITIS AND RHEUMATISM (2005)
Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists
DR Danforth et al.
FERTILITY AND STERILITY (2005)
The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice
D Meirow et al.
HUMAN REPRODUCTION (2004)
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey
N Salooja et al.
LANCET (2001)
Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents:: A preliminary report
BP Pacheco et al.
GYNECOLOGIC ONCOLOGY (2001)
Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy
Z Blumenfeld et al.
LUPUS (2000)
Share Paper
